{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:51:36Z","timestamp":1789419096331,"version":"build-2803163510"},"reference-count":128,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Lipids are a complex group of molecules in the body, essential as structural, functional and metabolic components. When disbalanced, they are regarded as a cardiovascular risk factor, traditionally in cholesterol level evaluation. However, due to their complex nature, much research is still needed for a comprehensive understanding of their role in atherosclerosis, especially in the young. Several new lipid biomarkers are emerging, some already researched to a point, such as lipoproteins and apolipoproteins. Other lipid molecules are also being increasingly researched, including oxidized forms due to oxidative inflammation in atherosclerosis, and sphingolipids. For many, even those less new, the atherogenic potential is not clear and no clinical recommendations are in place to aid the clinician in using them in everyday clinical practice. Moreover, lipids\u2019 involvement in atherogenesis in children has yet to be elucidated. This review summarizes the current knowledge on lipids as biomarkers of cardiovascular risk in the paediatric population.<\/jats:p>","DOI":"10.3390\/ijms24032237","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T03:48:08Z","timestamp":1674445688000},"page":"2237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Lipid Biomarkers and Atherosclerosis\u2014Old and New in Cardiovascular Risk in Childhood"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-6753","authenticated-orcid":false,"given":"Mirjam","family":"Mo\u010dnik","sequence":"first","affiliation":[{"name":"Department of Paediatrics, University Medical Centre Maribor, Ljubljanska Cesta 2, 2000 Maribor, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0634-3576","authenticated-orcid":false,"given":"Nata\u0161a","family":"Mar\u010dun Varda","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Medical Centre Maribor, Ljubljanska Cesta 2, 2000 Maribor, Slovenia"},{"name":"Faculty of Medicine, University of Maribor, Taborska 8, 2000 Maribor, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IPRP.S133088","article-title":"Cardiovascular disease as a leading cause of death: How are pharmacists getting involved?","volume":"8","author":"McNamara","year":"2019","journal-title":"Integr. Pharm. Res. Pract."},{"key":"ref_2","unstructured":"Feingold, K.R., and Anawalt, B. (2022, December 25). The Role of Lipids and Lipoproteins in Atherosclerosis, Comprehensive Endocrinology Book, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK343489\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00428-006-0176-7","article-title":"Atherosclerosis research from past to present\u2014On the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow","volume":"449","author":"Mayerl","year":"2006","journal-title":"Virchows Arch."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41598-017-00499-9","article-title":"Novel and traditional lipid-related biomarkers and their combinations in predicting coronary severity","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/CIRCGENETICS.114.000550","article-title":"Lipidomics: Quest for molecular lipid biomarkers in cardiovascular disease","volume":"7","author":"Hinterwirth","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1307S","DOI":"10.1093\/ajcn\/72.5.1307s","article-title":"Origin of atherosclerosis in childhood and adolescence","volume":"72","author":"McGill","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0828-282X(08)70570-1","article-title":"Perinatal and infant early atherosclerotic coronary lesions","volume":"24","author":"Milei","year":"2008","journal-title":"Can. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/pch\/14.3.177","article-title":"Childhood obesity and cardiovascular disease","volume":"14","author":"Bridger","year":"2009","journal-title":"Paediatr. Child Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1514S","DOI":"10.3945\/ajcn.2010.28701D","article-title":"Lifetime cardiovascular risk of childhood obesity","volume":"91","author":"Raghuveer","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-25979-6_1","article-title":"Lipids: From Chemical Structures, Biosynthesis, and Analyses to Industrial Applications","volume":"86","author":"Nakamura","year":"2016","journal-title":"Subcell. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a000588","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: An emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2011.03.021","article-title":"Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: The Cardiovascular Risk in Young Finns Study","volume":"159","author":"Juhola","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_13","unstructured":"Feingold, K.R., and Anawalt, B. (2022, December 25). Introduction to Lipids and Lipoproteins, Comprehensive Endocrinology Book, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK305896\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neurobiolaging.2004.05.009","article-title":"Cardiovascular risk factors in youth with implications for aging: The Bogalusa Heart Study","volume":"26","author":"Berenson","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.0000060923.07573.F2","article-title":"Obesity, insulin resistance, diabetes, and cardiovascular risk in children: An American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism)","volume":"107","author":"Steinberger","year":"2003","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000354224","article-title":"Body mass index or waist circumference: Which is the better predictor for hypertension and dyslipidemia in overweight\/obese children and adolescents? Association of cardiovascular risk related to body mass index or waist circumference","volume":"80","author":"Widhalm","year":"2013","journal-title":"Horm. Res. Paediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/VHRM.S2928","article-title":"Frequency of secondary dyslipidemia in obese children","volume":"4","author":"Korsten","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jacl.2015.06.008","article-title":"Combined dyslipidemia in childhood","volume":"9","author":"Kavey","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1080\/07315724.1992.10737984","article-title":"Early lesions of atherosclerosis in childhood and youth: Natural history and risk factors","volume":"11","author":"Strong","year":"1992","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.atherosclerosis.2009.06.006","article-title":"Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia","volume":"207","author":"Guardamagna","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.atherosclerosis.2009.07.034","article-title":"Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth","volume":"208","author":"Morrison","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jacc.2014.07.962","article-title":"Childhood obesity and adulthood cardiovascular disease: Quantifying the lifetime cumulative burden of cardiovascular risk factors","volume":"64","author":"Litwin","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jacc.2008.09.061","article-title":"The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study","volume":"53","author":"Magnussen","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1001\/jama.290.17.2271","article-title":"Childhood cardiovascular risk factors and carotid vascular changes in adulthood: The Bogalusa Heart Study","volume":"290","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1542\/peds.2005-1856","article-title":"Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: The Bogalusa Heart Study","volume":"118","author":"Srinivasan","year":"2006","journal-title":"Pediatrics"},{"key":"ref_26","first-page":"64","article-title":"AIP\u2014Atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice","volume":"52","year":"2006","journal-title":"Vnitr. Lek."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1399-5448.2008.00406.x","article-title":"The triglyceride\/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors","volume":"9","author":"Quijada","year":"2008","journal-title":"Pediatr. Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJMoa1010112","article-title":"Childhood adiposity, adult adiposity, and cardiovascular risk factors","volume":"365","author":"Juonala","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(06)69075-2","article-title":"Physical activity and clustered cardiovascular risk in children: A cross-sectional study (The European Youth Heart Study)","volume":"368","author":"Andersen","year":"2006","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ypmed.2014.08.014","article-title":"Physical activity and cardiovascular risk factors in children: Meta-analysis of randomized clinical trials","volume":"69","author":"Cesa","year":"2014","journal-title":"Prev. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(79)91375-8","article-title":"Are apolipoproteins better discriminators than lipids for atherosclerosis?","volume":"1","author":"Avogaro","year":"1979","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S0066-782X1999000600001","article-title":"Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?","volume":"72","author":"Manfroi","year":"1999","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCULATIONAHA.119.041149","article-title":"Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease","volume":"140","author":"Welsh","year":"2019","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/01.ATV.0000144010.55563.63","article-title":"Lipoprotein (a): An elusive cardiovascular risk factor","volume":"24","author":"Berglund","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.arcmed.2020.12.003","article-title":"Lipoprotein (a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic Experience","volume":"52","author":"Anastasiou","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_36","first-page":"101100","article-title":"Elevated Lipoprotein (a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol","volume":"42","author":"Gulayin","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1590\/S0103-05822013000400017","article-title":"Lipoprotein (a) and cardiovascular risk factors in children and adolescents","volume":"31","author":"Palmeira","year":"2013","journal-title":"Rev. Paul Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00431-002-1040-7","article-title":"Cardiovascular risk factors in children with obesity, hypertension and diabetes: Lipoprotein (a) levels and body mass index correlate with family history of cardiovascular disease","volume":"161","author":"Glowinska","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2022.04.021","article-title":"Lipoprotein (a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group","volume":"349","author":"Pederiva","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpeds.2011.01.038","article-title":"Lipoprotein (a) and family history of cardiovascular disease in children with familial dyslipidemias","volume":"159","author":"Guardamagna","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ijs.12136","article-title":"Review of lipid and lipoprotein (a) abnormalities in childhood arterial ischemic stroke","volume":"9","author":"Sultan","year":"2014","journal-title":"Int. J. Stroke"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2012.073833","article-title":"Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children","volume":"98","author":"Goldenberg","year":"2013","journal-title":"Haematologica"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s00246-018-1927-3","article-title":"Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population","volume":"39","author":"Qayum","year":"2018","journal-title":"Pediatr. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MED.0000000000000624","article-title":"Expert position statements: Comparison of recommendations for the care of adults and youth with elevated lipoprotein (a)","volume":"28","author":"Wilson","year":"2021","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0140-6736(01)06525-4","article-title":"Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study","volume":"358","author":"Tounian","year":"2001","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.nutres.2011.09.005","article-title":"The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis","volume":"31","author":"Jaimungal","year":"2011","journal-title":"Nutr. Res."},{"key":"ref_47","first-page":"34","article-title":"Apo B\/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal","volume":"8","author":"Tamang","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2796.2003.01276.x","article-title":"Apolipoprotein B and apolipoprotein A-I: Risk indicators of coronary heart disease and targets for lipid-modifying therapy","volume":"255","author":"Walldius","year":"2004","journal-title":"J. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.36660\/abc.20200540","article-title":"Obesity, Overweight, Body Adiposity and Cardiovascular Risk in Children and Adolescents","volume":"115","author":"Barroso","year":"2020","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s12098-010-0217-8","article-title":"Utility of ApoB\/ApoA1 ratio for the prediction of cardiovascular risk in children with metabolic syndrome","volume":"77","author":"Simsek","year":"2010","journal-title":"Indian J. Pediatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2265.2010.03953.x","article-title":"Apolipoprotein B\/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents","volume":"74","author":"Lee","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.atherosclerosis.2010.10.037","article-title":"Apolipoprotein B is related to arterial pulse wave velocity in young adults: The Cardiovascular Risk in Young Finns Study","volume":"214","author":"Koivistoinen","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2008.03.054","article-title":"Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: The cardiovascular risk in young Finns study","volume":"52","author":"Juonala","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpeds.2005.08.025","article-title":"Nontraditional cardiovascular risk factors in pediatric metabolic syndrome","volume":"148","author":"Retnakaran","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0021-9150(03)00003-0","article-title":"New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents","volume":"167","author":"Glowinska","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2007-1472","article-title":"Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: The Bogalusa Heart Study","volume":"121","author":"Frontini","year":"2008","journal-title":"Pediatrics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacc.2003.08.030","article-title":"Novel and traditional cardiovascular risk factors in children after Kawasaki disease: Implications for premature atherosclerosis","volume":"43","author":"Cheung","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3345\/kjp.2014.57.5.217","article-title":"Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease","volume":"57","author":"Cho","year":"2014","journal-title":"Korean J. Pediatr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpeds.2020.08.017","article-title":"Relationship of Apolipoproteins with Subclinical Cardiovascular Risk in Youth","volume":"227","author":"Czeck","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.atherosclerosis.2010.07.004","article-title":"The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study)","volume":"212","author":"Guardiola","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacl.2016.09.009","article-title":"Familial defective apolipoprotein B-100: A review","volume":"10","author":"Andersen","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1399-5448.2010.00710.x","article-title":"Cardiometabolic risk factors as apolipoprotein B, triglyceride\/HDL-cholesterol ratio and C-reactive protein, in adolescents with and without obesity: Cross-sectional study in middle class suburban children","volume":"12","author":"Musso","year":"2011","journal-title":"Pediatr. Diabetes"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.cjca.2017.08.004","article-title":"Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events","volume":"33","author":"Zhu","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCOUTCOMES.109.857771","article-title":"Arterial intima-media thickness, endothelial function, and apolipoproteins in adolescents frequently exposed to tobacco smoke","volume":"3","author":"Kallio","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jacc.2013.07.081","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: A randomized, double-blind, placebo-controlled trial","volume":"62","author":"Thomas","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1194\/jlr.M300253-JLR200","article-title":"Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease","volume":"44","author":"Olivieri","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"706323","DOI":"10.3389\/fped.2021.706323","article-title":"Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","article-title":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease","volume":"51","author":"Marais","year":"2019","journal-title":"Pathology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1542\/peds.94.4.489","article-title":"Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: The Cardiovascular Risk in Young Finns Study","volume":"94","author":"Porkka","year":"1994","journal-title":"Pediatrics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0021-9150(95)05762-5","article-title":"The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: The Bogalusa Heart Study","volume":"123","author":"Srinivasan","year":"1996","journal-title":"Atherosclerosis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000069275","article-title":"Influence of apolipoprotein e polymorphism on cardiovascular risk factors in obese children","volume":"47","author":"Guerra","year":"2003","journal-title":"Ann. Nutr. Metab."},{"key":"ref_72","first-page":"592","article-title":"Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: A 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study","volume":"45","author":"Raitakari","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jacl.2011.06.017","article-title":"The association of apolipoprotein E polymorphism and lipid levels in children with a family history of premature coronary artery disease","volume":"6","author":"Coskun","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0026-0495(96)90149-3","article-title":"The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The Cardiovascular Risk in Young Finns Study","volume":"45","author":"Taimela","year":"1996","journal-title":"Metabolism"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1651-2227.2002.tb00121.x","article-title":"Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant stanol esters in children: The STRIP study. Special Turku Coronary Risk Factor Intervention Project","volume":"91","author":"Tammi","year":"2002","journal-title":"Acta Paediatr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1469-8749.2005.tb01042.x","article-title":"Apolipoprotein E and brain injury: Implications for children","volume":"47","author":"Blackman","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopsych.2010.10.033","article-title":"IQ, educational attainment, memory and plasma lipids: Associations with apolipoprotein E genotype in 5995 children","volume":"70","author":"Taylor","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1203\/PDR.0b013e3181cb8e68","article-title":"Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children","volume":"67","author":"Acevedo","year":"2010","journal-title":"Pediatr. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-006-0065-1","article-title":"Oxidized low-density lipoprotein biomarkers in atherosclerosis","volume":"8","author":"Tsimikas","year":"2006","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"9P","DOI":"10.1016\/j.amjcard.2006.09.015","article-title":"Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease","volume":"98","author":"Tsimikas","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.mol.0000245255.40634.b5","article-title":"Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease","volume":"17","author":"Fraley","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/10408363.2014.992063","article-title":"Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases","volume":"52","author":"Trpkovic","year":"2015","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/oby.2011.21","article-title":"Circulating oxidized LDL and inflammation in extreme pediatric obesity","volume":"19","author":"Norris","year":"2011","journal-title":"Obesity"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1399-5448.2009.00640.x","article-title":"Relation of circulating oxidized LDL to obesity and insulin resistance in children","volume":"11","author":"Kelly","year":"2010","journal-title":"Pediatr. Diabetes"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7150\/ijms.20126","article-title":"Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese Children","volume":"14","author":"Manco","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/01.CIR.0000129304.98566.D8","article-title":"Determinants of arterial nitrate-mediated dilatation in children: Role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness","volume":"109","author":"Raitakari","year":"2004","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2265.2007.02849.x","article-title":"Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome","volume":"67","author":"Demirel","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1758-5996-7-4","article-title":"Bilirubin is independently associated with oxidized LDL levels in young obese patients","volume":"7","author":"Nascimento","year":"2015","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Jacobs, L., Emmerechts, J., Hoylaerts, M.F., Mathieu, C., Hoet, P.H., Nemery, B., and Nawrot, T.S. (2011). Traffic air pollution and oxidized LDL. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016200"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1373\/clinchem.2007.089953","article-title":"Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children","volume":"54","author":"Kelishadi","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/07853890.2011.590146","article-title":"Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study","volume":"44","author":"Mansikkaniemi","year":"2012","journal-title":"Ann. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/met.2010.0020","article-title":"Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome","volume":"8","author":"Kelishadi","year":"2010","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diabres.2012.01.009","article-title":"Broccoli sprouts powder could improve serum triglyceride and oxidized LDL\/LDL-cholesterol ratio in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial","volume":"96","author":"Bahadoran","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jdiacomp.2015.03.015","article-title":"Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers","volume":"29","author":"Marin","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apoB-100-containing lipoproteins: A biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomark. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: Five-year prospective results from the Bruneck study","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","article-title":"Oxidized phospholipids, lipoprotein (a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: Prospective results from the Bruneck study","volume":"27","author":"Kiechl","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.numecd.2010.06.002","article-title":"Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children","volume":"22","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e00554","DOI":"10.1002\/prp2.554","article-title":"LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis","volume":"8","author":"Amar","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/pbc.21522","article-title":"Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver","volume":"50","author":"Zidan","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"969081","DOI":"10.3389\/fped.2022.969081","article-title":"Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis","volume":"10","author":"Colantuono","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MED.0000000000000466","article-title":"Controversy over the atherogenicity of lipoprotein-X","volume":"26","author":"Miida","year":"2019","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Pantazi, D., Tellis, C., and Tselepis, A.D. (Biofactors, 2022). \u201cSI: PAF\u201d Oxidized phospholipids and lipoprotein-associated phospholipase A2 (Lp-PLA2) in atherosclerotic cardiovascular disease: An update, Biofactors, epub ahead of print.","DOI":"10.1002\/biof.1890"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Dimitroglou, Y., Sakalidis, A., Mavroudis, A., Kalantzis, C., Valatsou, A., Andrikou, I., Christofi, A., Mantzouranis, E., Kachrimanidis, I., and Bei, E. (Curr. Top. Med. Chem., 2022). Lipoprotein-associated phospholipase A2 in coronary artery disease, Curr. Top. Med. Chem., epub ahead of print.","DOI":"10.2174\/1568026623666221027145545"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13167-011-0063-4","article-title":"Lipoprotein associated phospholipase A(2): Role in atherosclerosis and utility as a biomarker for cardiovascular risk","volume":"2","author":"Colley","year":"2011","journal-title":"EPMA J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4103\/jnrp.jnrp_97_18","article-title":"Lipoprotein-Associated Phospholipase A2 is Linked with Poor Cardio-Metabolic Profile in Patients with Ischemic Stroke: A Study of Effects of Statins","volume":"9","author":"Alkuraishy","year":"2018","journal-title":"J. Neurosci. Rural Pract."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/0004563216671338","article-title":"Lipoprotein-associated phospholipase A2: A new marker to determine cardiovascular risk in hypercholesterolemic dyslipidaemic children","volume":"54","author":"Levent","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jacl.2010.11.001","article-title":"Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: Effect of pravastatin","volume":"5","author":"Ryu","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1515\/jpem-2015-0365","article-title":"Lipoprotein-associated phospholipase A2 activity and low-density lipoprotein subfractions after a 2-year treatment with atorvastatin in adolescents with type 1 diabetes","volume":"29","author":"Krebs","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s12098-021-03806-5","article-title":"Increased Cholesteryl Ester Transfer Protein and Lipoprotein-Associated Phospholipase A2 Activities in Children and Adolescents Presenting High Triglyceride\/High-Density Lipoprotein Cholesterol (TG\/HDL-C) Ratio","volume":"88","author":"Ferraro","year":"2021","journal-title":"Indian J. Pediatr."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1515\/cclm-2014-1081","article-title":"Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children","volume":"53","author":"Sakka","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-511X-12-19","article-title":"Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: The healthy young cross-sectional study","volume":"12","author":"Damasceno","year":"2013","journal-title":"Lipids Health Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e004923","DOI":"10.1161\/JAHA.116.004923","article-title":"Endothelial Dysfunction in Children With Obstructive Sleep Apnea Is Associated With Elevated Lipoprotein-Associated Phospholipase A2 Plasma Activity Levels","volume":"6","author":"Philby","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"854079","DOI":"10.3389\/fped.2022.854079","article-title":"The Relationship Between Lipoprotein-Associated Phospholipase-A2 and Coronary Artery Aneurysm in Children with Kawasaki Disease","volume":"10","author":"Cheng","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/187152511796196542","article-title":"Association of lipoprotein-associated phospholipase A2 activity with components of the metabolic syndrome in apparently healthy boys","volume":"9","author":"Hirschler","year":"2011","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Patel, V.B., and Preedy, V.R. (2022). Biomarkers in Nutrition. Biomarkers in Disease: Methods, Discoveries and Applications, Springer.","DOI":"10.1007\/978-3-031-07389-2"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s42255-019-0134-8","article-title":"Metabolic Messengers: Ceramides","volume":"1","author":"Summers","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4062\/biomolther.2020.218","article-title":"Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease","volume":"29","author":"Song","year":"2021","journal-title":"Biomol. Ther."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2021.04.021","article-title":"Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies","volume":"327","author":"McGurk","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"107734","DOI":"10.1016\/j.jdiacomp.2020.107734","article-title":"Role of ceramides in the pathogenesis of diabetes mellitus and its complications","volume":"35","author":"Mandal","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma Ceramides","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12944-018-0855-9","article-title":"Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease","volume":"17","author":"Wasilewska","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Olson, E., Suh, J.H., Schwarz, J.M., Noworolski, S.M., Jones, G.M., Barber, J.R., Erkin-Cakmak, A., Mulligan, K., Lustig, R.H., and Mietus-Snyder, M. (2022). Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity. Nutrients, 14.","DOI":"10.3390\/nu14071432"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41366-018-0291-y","article-title":"Maternal obesity leads to long-term altered levels of plasma ceramides in the offspring as revealed by a longitudinal lipidomic study in children","volume":"43","author":"Croyal","year":"2019","journal-title":"Int. J. Obes."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-013-2642-1","article-title":"Ceramides and cardiac function in children with chronic kidney disease","volume":"29","author":"Mitsnefes","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/emmm.201302781","article-title":"Farber disease: Understanding a fatal childhood disorder and dissecting ceramide biology","volume":"5","author":"Sands","year":"2013","journal-title":"EMBO Mol. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:13:58Z","timestamp":1760120038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":128,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032237"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032237","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}